• Linoleic Acid (C18:2): Practical Protocols and QC for Lab Us

  2026-06-12

  Linoleic Acid (C18:2(9Z,12Z)) is a key reagent for modeling oxidative stress, membrane dynamics, and nutritional deficiency in vitro and in vivo. This guide provides actionable setup, protocol, and troubleshooting details for effective use in cell-based assays and animal models. It is not intended for clinical or diagnostic applications where direct mechanistic evidence or clinical endpoints are required.

• HyperScript First-Strand cDNA Synthesis Kit: Advanced Workfl

  2026-06-11

  The HyperScript First-Strand cDNA Synthesis Kit empowers researchers to tackle challenging RNA templates with high fidelity, enabling robust gene expression analyses even for low-abundance targets. Its advanced enzyme engineering and versatile primer options streamline PCR and qPCR workflows, setting a new standard in experimental reproducibility.

• Baicalein (5,6,7-trihydroxy-2-phenylchromen-4-one) in Cancer

  2026-06-11

  Baicalein is a high-purity 12-LOX inhibitor that enables reproducible modulation of apoptosis and inflammation pathways in cancer research. This guide details optimized protocols, advanced troubleshooting, and workflow enhancements—empowering researchers to address complex signaling questions with confidence.

• Empowering Cancer Research with JNJ-26481585 (Quisinostat):

  2026-06-10

  This article delivers a practical, evidence-based exploration of JNJ-26481585 (Quisinostat), SKU A4090, as a robust HDAC inhibitor for apoptosis induction, cell proliferation assays, and tumor growth studies. Designed for biomedical researchers, it addresses real laboratory challenges, protocol optimization, and data interpretation, linking directly to validated workflows and supplier reliability.

• Boc-D-FMK: Applied Caspase Inhibition for Apoptosis Research

  2026-06-10

  Boc-D-FMK from APExBIO enables robust, reproducible caspase inhibition in both cellular and in vivo models of apoptosis and inflammation. This guide delivers actionable workflows, practical troubleshooting, and domain-bridging insights for researchers deploying this pan-caspase inhibitor in advanced disease modeling.

• Tumor-Targeted PAD4 Inhibitors Disrupt NETs to Limit Metasta

  2026-06-09

  This study presents PBA-modified PAD4 inhibitors that selectively target tumor and neutrophil PAD4, effectively disrupting the PAD4-H3cit-NETs pathway and limiting tumor growth and metastasis in vivo. The findings highlight a promising strategy for precise tumor microenvironment modulation with reduced off-target toxicity.

• GSK-923295 and CENP-E: Charting the Next Era in Mitotic Rese

  2026-06-09

  This thought-leadership article synthesizes new mechanistic insights into centromere biology—particularly the interplay between CENP-E and CTCF—with actionable guidance for translational researchers leveraging GSK-923295. The piece integrates evidence from foundational studies, critically evaluates the competitive landscape, and provides protocol-level recommendations to elevate mitosis-focused cancer research.

• Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit

  2026-06-08

  The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit enables precise separation of proteins and peptides in the 1–10 kDa range, a challenge for standard Tris-glycine SDS-PAGE methods. This kit is intended for research workflows analyzing low molecular weight proteins, and is not suitable for diagnostic or clinical applications.

• DiD (DiDC 18 (5)): Advanced Membrane Tracking for Macrophage

  2026-06-08

  Explore how DiD (DiDC 18 (5)) enables next-generation plasma membrane imaging in macrophage biology and inflammation studies. This article reveals unique assay strategies and insights not covered in other resources.

• RG7388 MDM2 Antagonist: Precision p53 Pathway Activation in

  2026-06-07

  RG7388, a next-generation, highly selective MDM2 antagonist, empowers researchers to induce robust p53 pathway activation and apoptosis in wild-type p53 cancer cells. This article translates the latest biomarker-driven insights and workflow optimizations into actionable strategies for maximizing RG7388’s utility in both cell-based and in vivo oncology models.

• ML385: Selective NRF2 Inhibitor for Cancer and Redox Researc

  2026-06-06

  ML385 is a potent, selective NRF2 inhibitor widely applied in cancer and oxidative stress research. It provides mechanistic control of NRF2 signaling in vitro and in vivo, enabling the study of therapeutic resistance and redox biology. Peer-reviewed evidence supports its specificity and efficacy at molecular and organismal levels.

• Elobixibat Hydrate: Molecular Insights & Metabolic Modulatio

  2026-06-05

  Explore Elobixibat hydrate, a selective ileal bile acid transporter inhibitor, through a molecular and metabolic lens. This article reveals new mechanistic insights and clinical implications for chronic idiopathic constipation and metabolic disorders, distinguishing itself from standard application guides.

• MDV3100 (Enzalutamide): Optimizing Prostate Cancer Research

  2026-06-05

  MDV3100 (Enzalutamide) empowers researchers to dissect androgen receptor signaling, apoptosis, and resistance mechanisms in prostate and AR-driven cancers. This article details actionable workflows, troubleshooting strategies, and the latest evidence to elevate the reliability and impact of your AR pathway studies.

• Optimizing Synthetic mRNA with Anti Reverse Cap Analog (ARCA

  2026-06-04

  This article explores practical laboratory scenarios where Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G (SKU B8175) overcomes challenges in synthetic mRNA workflows. Drawing on peer-reviewed evidence and real-world protocol optimization, we demonstrate how ARCA enhances translation, reproducibility, and workflow efficiency for biomedical researchers conducting cell-based assays.

• PKH26 Red Fluorescent Cell Linker Kit: Technical Workflow Gu

  2026-06-04

  The PKH26 Red Fluorescent Cell Linker Kit enables stable, membrane-specific labeling for robust cell tracing and proliferation detection in vitro and in vivo. It is not suitable for intracellular or non-membrane applications, and protocol adherence is essential for reproducible, low-toxicity results.

408 records 12/28 page Previous Next First page 上5页 1112131415 下5页 Last page